APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung Surfactants

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lung Surfactants Market Analysis and Forecast 2026-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchLung Surfactants Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Surfactants Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Lung Surfactants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Surfactants Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Surfactants Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lung Surfactants market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lung Surfactants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lung Surfactants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lung Surfactants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lung Surfactants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lung Surfactants include Aviva Systems Biology Corporation, Chiesi Farmaceutici, Lyomark Pharma, ONY Biotech, Windtree Therapeutics and AbbVie, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lung Surfactants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lung Surfactants, also provides the sales of main regions and countries. Of the upcoming market potential for Lung Surfactants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lung Surfactants sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lung Surfactants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lung Surfactants sales, projected growth trends, production technology, application and end-user industry.

Lung Surfactants Segment by Company

Aviva Systems Biology Corporation

Chiesi Farmaceutici

Lyomark Pharma

ONY Biotech

Windtree Therapeutics

AbbVie

Lung Surfactants Segment by Type

Intratracheal

Injectable

Lung Surfactants Segment by Application

Special Clinic

Hospital

Recovery Center

Lung Surfactants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Surfactants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Surfactants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Surfactants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lung Surfactants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lung Surfactants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Surfactants sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lung Surfactants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Intratracheal Major Manufacturers Table 3. Injectable Major Manufacturers Table 4. Global Lung Surfactants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Special Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Recovery Center Major Manufacturers Table 8. Lung Surfactants Industry Trends Table 9. Lung Surfactants Industry Drivers Table 10. Lung Surfactants Industry Opportunities and Challenges Table 11. Lung Surfactants Industry Restraints Table 12. Global Lung Surfactants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Lung Surfactants Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Lung Surfactants Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Lung Surfactants Revenue Market Share by Region (2021-2026) Table 16. Global Lung Surfactants Revenue Market Share by Region (2027-2032) Table 17. Global Lung Surfactants Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Lung Surfactants Sales by Region (2021-2026) & (K Units) Table 19. Global Lung Surfactants Sales by Region (2027-2032) & (K Units) Table 20. Global Lung Surfactants Sales Market Share by Region (2021-2026) Table 21. Global Lung Surfactants Sales Market Share by Region (2027-2032) Table 22. Global Lung Surfactants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Lung Surfactants Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Lung Surfactants Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Lung Surfactants Sales Market Share by Manufacturers (2021-2026) Table 26. Global Lung Surfactants Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Lung Surfactants Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Lung Surfactants Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Lung Surfactants Manufacturers, Product Type & Application Table 30. Global Lung Surfactants Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Lung Surfactants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Lung Surfactants Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Lung Surfactants Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Lung Surfactants Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Lung Surfactants Revenue Market Share by Type (2021-2026) Table 37. Global Lung Surfactants Revenue Market Share by Type (2027-2032) Table 38. Global Lung Surfactants Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 40. Global Lung Surfactants Sales by Type (2027-2032) & (K Units) Table 41. Global Lung Surfactants Sales Market Share by Type (2021-2026) Table 42. Global Lung Surfactants Sales Market Share by Type (2027-2032) Table 43. Global Lung Surfactants Price by Type (2021-2026) & (US$/Unit) Table 44. Global Lung Surfactants Price by Type (2027-2032) & (US$/Unit) Table 45. Global Lung Surfactants Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Lung Surfactants Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Lung Surfactants Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Lung Surfactants Revenue Market Share by Application (2021-2026) Table 49. Global Lung Surfactants Revenue Market Share by Application (2027-2032) Table 50. Global Lung Surfactants Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 52. Global Lung Surfactants Sales by Application (2027-2032) & (K Units) Table 53. Global Lung Surfactants Sales Market Share by Application (2021-2026) Table 54. Global Lung Surfactants Sales Market Share by Application (2027-2032) Table 55. Global Lung Surfactants Price by Application (2021-2026) & (US$/Unit) Table 56. Global Lung Surfactants Price by Application (2027-2032) & (US$/Unit) Table 57. Aviva Systems Biology Corporation Company Information Table 58. Aviva Systems Biology Corporation Business Overview Table 59. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Aviva Systems Biology Corporation Lung Surfactants Product Portfolio Table 61. Aviva Systems Biology Corporation Recent Development Table 62. Chiesi Farmaceutici Company Information Table 63. Chiesi Farmaceutici Business Overview Table 64. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Chiesi Farmaceutici Lung Surfactants Product Portfolio Table 66. Chiesi Farmaceutici Recent Development Table 67. Lyomark Pharma Company Information Table 68. Lyomark Pharma Business Overview Table 69. Lyomark Pharma Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Lyomark Pharma Lung Surfactants Product Portfolio Table 71. Lyomark Pharma Recent Development Table 72. ONY Biotech Company Information Table 73. ONY Biotech Business Overview Table 74. ONY Biotech Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. ONY Biotech Lung Surfactants Product Portfolio Table 76. ONY Biotech Recent Development Table 77. Windtree Therapeutics Company Information Table 78. Windtree Therapeutics Business Overview Table 79. Windtree Therapeutics Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Windtree Therapeutics Lung Surfactants Product Portfolio Table 81. Windtree Therapeutics Recent Development Table 82. AbbVie Company Information Table 83. AbbVie Business Overview Table 84. AbbVie Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. AbbVie Lung Surfactants Product Portfolio Table 86. AbbVie Recent Development Table 87. North America Lung Surfactants Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Lung Surfactants Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 90. North America Lung Surfactants Sales by Type (2027-2032) & (K Units) Table 91. North America Lung Surfactants Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Lung Surfactants Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Lung Surfactants Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Lung Surfactants Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 96. North America Lung Surfactants Sales by Application (2027-2032) & (K Units) Table 97. North America Lung Surfactants Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Lung Surfactants Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Lung Surfactants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Lung Surfactants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Lung Surfactants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Lung Surfactants Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 104. North America Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 105. North America Lung Surfactants Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Lung Surfactants Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 108. Canada Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 109. Europe Lung Surfactants Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Lung Surfactants Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 112. Europe Lung Surfactants Sales by Type (2027-2032) & (K Units) Table 113. Europe Lung Surfactants Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Lung Surfactants Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Lung Surfactants Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Lung Surfactants Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 118. Europe Lung Surfactants Sales by Application (2027-2032) & (K Units) Table 119. Europe Lung Surfactants Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Lung Surfactants Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Lung Surfactants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Lung Surfactants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Lung Surfactants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Lung Surfactants Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 126. Europe Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 127. Europe Lung Surfactants Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Lung Surfactants Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 130. France Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 131. U.K. Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 132. Italy Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 134. Nordic Countries Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 135. China Lung Surfactants Revenue by Type (2021-2026) & (US$ Million) Table 136. China Lung Surfactants Revenue by Type (2027-2032) & (US$ Million) Table 137. China Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 138. China Lung Surfactants Sales by Type (2027-2032) & (K Units) Table 139. China Lung Surfactants Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Lung Surfactants Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Lung Surfactants Revenue by Application (2021-2026) & (US$ Million) Table 142. China Lung Surfactants Revenue by Application (2027-2032) & (US$ Million) Table 143. China Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 144. China Lung Surfactants Sales by Application (2027-2032) & (K Units) Table 145. China Lung Surfactants Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Lung Surfactants Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Lung Surfactants Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Lung Surfactants Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 150. Asia Lung Surfactants Sales by Type (2027-2032) & (K Units) Table 151. Asia Lung Surfactants Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Lung Surfactants Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Lung Surfactants Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Lung Surfactants Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 156. Asia Lung Surfactants Sales by Application (2027-2032) & (K Units) Table 157. Asia Lung Surfactants Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Lung Surfactants Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Lung Surfactants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Lung Surfactants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Lung Surfactants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Lung Surfactants Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. Asia Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 164. Asia Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 165. Asia Lung Surfactants Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Lung Surfactants Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 168. South Korea Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 169. India Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 170. Australia Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Lung Surfactants Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Lung Surfactants Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 176. SAMEA Lung Surfactants Sales by Type (2027-2032) & (K Units) Table 177. SAMEA Lung Surfactants Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Lung Surfactants Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Lung Surfactants Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Lung Surfactants Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 182. SAMEA Lung Surfactants Sales by Application (2027-2032) & (K Units) Table 183. SAMEA Lung Surfactants Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Lung Surfactants Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Lung Surfactants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Lung Surfactants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Lung Surfactants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Lung Surfactants Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. SAMEA Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 190. SAMEA Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 191. SAMEA Lung Surfactants Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Lung Surfactants Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 194. Argentina Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 195. Chile Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 196. Colombia Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 197. Peru Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 199. Israel Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 200. UAE Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 201. Turkey Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 202. Iran Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 203. Egypt Lung Surfactants Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Lung Surfactants Distributors List Table 207. Lung Surfactants Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Lung Surfactants Image Figure 2. Global Lung Surfactants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lung Surfactants Market Size Share 2021 VS 2025 VS 2032 Figure 4. Intratracheal Image Figure 5. Injectable Image Figure 6. Global Lung Surfactants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lung Surfactants Market Size Share 2021 VS 2025 VS 2032 Figure 8. Special Clinic Image Figure 9. Hospital Image Figure 10. Recovery Center Image Figure 11. Global Lung Surfactants Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lung Surfactants Revenue (2021-2032) & (US$ Million) Figure 13. Global Lung Surfactants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Lung Surfactants Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Lung Surfactants Revenue Market Share by Region (2021-2032) Figure 16. Global Lung Surfactants Sales (2021-2032) & (K Units) Figure 17. Global Lung Surfactants Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Lung Surfactants Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Lung Surfactants Sales YoY (2021-2032) & (K Units) Figure 20. Europe Lung Surfactants Sales YoY (2021-2032) & (K Units) Figure 21. China Lung Surfactants Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Lung Surfactants Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Lung Surfactants Sales YoY (2021-2032) & (K Units) Figure 24. Global Lung Surfactants Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Lung Surfactants Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Lung Surfactants Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Lung Surfactants Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Lung Surfactants Revenue Market Share by Type (2021-2032) Figure 30. Global Lung Surfactants Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Lung Surfactants Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Lung Surfactants Sales Market Share by Type (2021-2032) Figure 33. Global Lung Surfactants Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Lung Surfactants Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Lung Surfactants Revenue Market Share by Application (2021-2032) Figure 36. Global Lung Surfactants Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Lung Surfactants Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Lung Surfactants Sales Market Share by Application (2021-2032) Figure 39. North America Lung Surfactants Revenue Share by Type (2021-2032) Figure 40. North America Lung Surfactants Sales Share by Type (2021-2032) Figure 41. North America Lung Surfactants Revenue Share by Application (2021-2032) Figure 42. North America Lung Surfactants Sales Share by Application (2021-2032) Figure 43. North America Lung Surfactants Revenue Share by Country (2021-2032) Figure 44. North America Lung Surfactants Sales Share by Country (2021-2032) Figure 45. Europe Lung Surfactants Revenue Share by Type (2021-2032) Figure 46. Europe Lung Surfactants Sales Share by Type (2021-2032) Figure 47. Europe Lung Surfactants Revenue Share by Application (2021-2032) Figure 48. Europe Lung Surfactants Sales Share by Application (2021-2032) Figure 49. Europe Lung Surfactants Revenue Share by Country (2021-2032) Figure 50. Europe Lung Surfactants Sales Share by Country (2021-2032) Figure 51. China Lung Surfactants Revenue Share by Type (2021-2032) Figure 52. China Lung Surfactants Sales Share by Type (2021-2032) Figure 53. China Lung Surfactants Revenue Share by Application (2021-2032) Figure 54. China Lung Surfactants Sales Share by Application (2021-2032) Figure 55. Asia Lung Surfactants Revenue Share by Type (2021-2032) Figure 56. Asia Lung Surfactants Sales Share by Type (2021-2032) Figure 57. Asia Lung Surfactants Revenue Share by Application (2021-2032) Figure 58. Asia Lung Surfactants Sales Share by Application (2021-2032) Figure 59. Asia Lung Surfactants Revenue Share by Country (2021-2032) Figure 60. Asia Lung Surfactants Sales Share by Country (2021-2032) Figure 61. SAMEA Lung Surfactants Revenue Share by Type (2021-2032) Figure 62. SAMEA Lung Surfactants Sales Share by Type (2021-2032) Figure 63. SAMEA Lung Surfactants Revenue Share by Application (2021-2032) Figure 64. SAMEA Lung Surfactants Sales Share by Application (2021-2032) Figure 65. SAMEA Lung Surfactants Revenue Share by Country (2021-2032) Figure 66. SAMEA Lung Surfactants Sales Share by Country (2021-2032) Figure 67. Lung Surfactants Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Lung Surfactants Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Intratracheal
  • Injectable
Applications
  • Special Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Aviva Systems Biology Corporation
  • Chiesi Farmaceutici
  • Lyomark Pharma
  • ONY Biotech
  • Windtree Therapeutics
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lung Surfactants Market by Type
  3. 1.2.1 Global Lung Surfactants Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Intratracheal
  5. 1.2.3 Injectable
  6. 1.3 Lung Surfactants Market by Application
  7. 1.3.1 Global Lung Surfactants Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Special Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Recovery Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Lung Surfactants Market Dynamics
  1. 2.1 Lung Surfactants Industry Trends
  2. 2.2 Lung Surfactants Industry Drivers
  3. 2.3 Lung Surfactants Industry Opportunities and Challenges
  4. 2.4 Lung Surfactants Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lung Surfactants Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lung Surfactants Revenue by Region
  3. 3.2.1 Global Lung Surfactants Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lung Surfactants Revenue by Region (2021-2026)
  5. 3.2.3 Global Lung Surfactants Revenue by Region (2027-2032)
  6. 3.2.4 Global Lung Surfactants Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lung Surfactants Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lung Surfactants Sales by Region
  9. 3.4.1 Global Lung Surfactants Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lung Surfactants Sales by Region (2021-2026)
  11. 3.4.3 Global Lung Surfactants Sales by Region (2027-2032)
  12. 3.4.4 Global Lung Surfactants Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lung Surfactants Revenue by Manufacturers
  2. 4.1.1 Global Lung Surfactants Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lung Surfactants Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lung Surfactants Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lung Surfactants Sales by Manufacturers
  6. 4.2.1 Global Lung Surfactants Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lung Surfactants Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lung Surfactants Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lung Surfactants Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lung Surfactants Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lung Surfactants Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lung Surfactants Manufacturers, Product Type & Application
  13. 4.7 Global Lung Surfactants Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lung Surfactants Market CR5 and HHI
  16. 4.8.2 2025 Lung Surfactants Tier 1, Tier 2, and Tier 3
5 Lung Surfactants Market by Type
  1. 5.1 Global Lung Surfactants Revenue by Type
  2. 5.1.1 Global Lung Surfactants Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lung Surfactants Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lung Surfactants Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lung Surfactants Sales by Type
  6. 5.2.1 Global Lung Surfactants Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lung Surfactants Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lung Surfactants Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lung Surfactants Price by Type
6 Lung Surfactants Market by Application
  1. 6.1 Global Lung Surfactants Revenue by Application
  2. 6.1.1 Global Lung Surfactants Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lung Surfactants Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lung Surfactants Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lung Surfactants Sales by Application
  6. 6.2.1 Global Lung Surfactants Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lung Surfactants Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lung Surfactants Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lung Surfactants Price by Application
7 Company Profiles
  1. 7.1 Aviva Systems Biology Corporation
  2. 7.1.1 Aviva Systems Biology Corporation Company Information
  3. 7.1.2 Aviva Systems Biology Corporation Business Overview
  4. 7.1.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aviva Systems Biology Corporation Lung Surfactants Product Portfolio
  6. 7.1.5 Aviva Systems Biology Corporation Recent Developments
  7. 7.2 Chiesi Farmaceutici
  8. 7.2.1 Chiesi Farmaceutici Company Information
  9. 7.2.2 Chiesi Farmaceutici Business Overview
  10. 7.2.3 Chiesi Farmaceutici Lung Surfactants Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Chiesi Farmaceutici Lung Surfactants Product Portfolio
  12. 7.2.5 Chiesi Farmaceutici Recent Developments
  13. 7.3 Lyomark Pharma
  14. 7.3.1 Lyomark Pharma Company Information
  15. 7.3.2 Lyomark Pharma Business Overview
  16. 7.3.3 Lyomark Pharma Lung Surfactants Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lyomark Pharma Lung Surfactants Product Portfolio
  18. 7.3.5 Lyomark Pharma Recent Developments
  19. 7.4 ONY Biotech
  20. 7.4.1 ONY Biotech Company Information
  21. 7.4.2 ONY Biotech Business Overview
  22. 7.4.3 ONY Biotech Lung Surfactants Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 ONY Biotech Lung Surfactants Product Portfolio
  24. 7.4.5 ONY Biotech Recent Developments
  25. 7.5 Windtree Therapeutics
  26. 7.5.1 Windtree Therapeutics Company Information
  27. 7.5.2 Windtree Therapeutics Business Overview
  28. 7.5.3 Windtree Therapeutics Lung Surfactants Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Windtree Therapeutics Lung Surfactants Product Portfolio
  30. 7.5.5 Windtree Therapeutics Recent Developments
  31. 7.6 AbbVie
  32. 7.6.1 AbbVie Company Information
  33. 7.6.2 AbbVie Business Overview
  34. 7.6.3 AbbVie Lung Surfactants Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AbbVie Lung Surfactants Product Portfolio
  36. 7.6.5 AbbVie Recent Developments
8 North America
  1. 8.1 North America Lung Surfactants Market Size by Type
  2. 8.1.1 North America Lung Surfactants Revenue by Type (2021-2032)
  3. 8.1.2 North America Lung Surfactants Sales by Type (2021-2032)
  4. 8.1.3 North America Lung Surfactants Price by Type (2021-2032)
  5. 8.2 North America Lung Surfactants Market Size by Application
  6. 8.2.1 North America Lung Surfactants Revenue by Application (2021-2032)
  7. 8.2.2 North America Lung Surfactants Sales by Application (2021-2032)
  8. 8.2.3 North America Lung Surfactants Price by Application (2021-2032)
  9. 8.3 North America Lung Surfactants Market Size by Country
  10. 8.3.1 North America Lung Surfactants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lung Surfactants Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lung Surfactants Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Lung Surfactants Market Size by Type
  2. 9.1.1 Europe Lung Surfactants Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lung Surfactants Sales by Type (2021-2032)
  4. 9.1.3 Europe Lung Surfactants Price by Type (2021-2032)
  5. 9.2 Europe Lung Surfactants Market Size by Application
  6. 9.2.1 Europe Lung Surfactants Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lung Surfactants Sales by Application (2021-2032)
  8. 9.2.3 Europe Lung Surfactants Price by Application (2021-2032)
  9. 9.3 Europe Lung Surfactants Market Size by Country
  10. 9.3.1 Europe Lung Surfactants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lung Surfactants Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lung Surfactants Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Lung Surfactants Market Size by Type
  2. 10.1.1 China Lung Surfactants Revenue by Type (2021-2032)
  3. 10.1.2 China Lung Surfactants Sales by Type (2021-2032)
  4. 10.1.3 China Lung Surfactants Price by Type (2021-2032)
  5. 10.2 China Lung Surfactants Market Size by Application
  6. 10.2.1 China Lung Surfactants Revenue by Application (2021-2032)
  7. 10.2.2 China Lung Surfactants Sales by Application (2021-2032)
  8. 10.2.3 China Lung Surfactants Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lung Surfactants Market Size by Type
  2. 11.1.1 Asia Lung Surfactants Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lung Surfactants Sales by Type (2021-2032)
  4. 11.1.3 Asia Lung Surfactants Price by Type (2021-2032)
  5. 11.2 Asia Lung Surfactants Market Size by Application
  6. 11.2.1 Asia Lung Surfactants Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lung Surfactants Sales by Application (2021-2032)
  8. 11.2.3 Asia Lung Surfactants Price by Application (2021-2032)
  9. 11.3 Asia Lung Surfactants Market Size by Country
  10. 11.3.1 Asia Lung Surfactants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lung Surfactants Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lung Surfactants Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lung Surfactants Market Size by Type
  2. 12.1.1 SAMEA Lung Surfactants Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lung Surfactants Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lung Surfactants Price by Type (2021-2032)
  5. 12.2 SAMEA Lung Surfactants Market Size by Application
  6. 12.2.1 SAMEA Lung Surfactants Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lung Surfactants Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lung Surfactants Price by Application (2021-2032)
  9. 12.3 SAMEA Lung Surfactants Market Size by Country
  10. 12.3.1 SAMEA Lung Surfactants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lung Surfactants Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lung Surfactants Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lung Surfactants Value Chain Analysis
  2. 13.1.1 Lung Surfactants Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lung Surfactants Production Mode & Process
  6. 13.2 Lung Surfactants Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lung Surfactants Distributors
  9. 13.2.3 Lung Surfactants Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst